[ 11 C]Choline Positron Emission Tomography/Computerized Tomography to Restage Prostate Cancer Cases With Biochemical Failure After Radical Prostatectomy and No Disease Evidence on Conventional Imaging-Reference-Cited by-同舟云学术

[ 11 C]Choline Positron Emission Tomography/Computerized Tomography to Restage Prostate Cancer Cases With Biochemical Failure After Radical Prostatectomy and No Disease Evidence on Conventional Imaging

Published:2010-09 Issue:3 Volume:184 Page:938-943
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Giovacchini Giampiero¹,Picchio Maria²,Briganti Alberto³,Cozzarini Cesare⁴,Scattoni Vincenzo³,Salonia Andrea³,Landoni Claudio²,Gianolli Luigi²,Di Muzio Nadia⁴,Rigatti Patrizio³,Montorsi Francesco³,Messa Cristina¹⁵⁶

Affiliation:

1. Center for Molecular Bioimaging, University of Milano-Bicocca, Milan, Italy

2. Department of Nuclear Medicine, San Raffaele Scientific Institute, Milan, Italy

3. Department of Urology, San Raffaele Scientific Institute, Milan, Italy

4. Department of Radiation Oncology, San Raffaele Scientific Institute, Milan, Italy

5. Institute for Bioimaging and Molecular Physiology, National Research Council, Milan, Italy

6. Department of Nuclear Medicine, San Gerardo Hospital, Monza, Italy

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. Natural history of progression after PSA elevation following radical prostatectomy;Pound;JAMA,1999

2. Comparison of [18F]fluorocholine and [18F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer;Price;J Urol,2002

3. [11C]choline positron emission tomography for the evaluation after treatment of localized prostate cancer;de Jong;Eur Urol,2003

4. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography;Picchio;J Urol,2003

5. Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?;Heinisch;Mol Imaging Biol,2006

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial;Cancer Imaging;2023-06-08

2. Imaging-based representation and stratification of intra-tumor heterogeneity via tree-edit distance;Scientific Reports;2022-11-15

3. [18F]FMCH PET/CT biomarkers and similarity analysis to refine the definition of oligometastatic prostate cancer;EJNMMI Research;2021-11-27

4. PET/CT Imaging of Prostate Cancer. Modern Versions of Radiopharmaceuticals;Journal of oncology: diagnostic radiology and radiotherapy;2021-06-22

5. Evaluation of Hybrid ⁶⁸Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy;J NUCL MED;2020